OnabotulinumtoxinA Significantly Improves Urinary Incontinence and Quality of Life in Overactive Bladder Patients Regardless of Incontinence Severity at Baseline

Research Type

Clinical

Abstract Category

Overactive Bladder

Links
	Abstract 167
	Updates on the Use of Botulinum Toxin Scientific Podium Short Oral Session 10
	Wednesday 7th October 2015
	14:30 - 14:37
	210AE
	Overactive Bladder Incontinence Quality of Life (QoL)
	1. USC Institute of Urology, Los Angeles, CA, USA, 2. Orange County Urology Associates, Laguna Hills, CA, USA, 3. Cleveland Clinic, Cleveland, OH, USA, 4. Kliniken Maria Hilf GmbH, Mönchengladbach, Germany, 5. Bristol Urological Institute, Bristol, UK, 6. Allergan, Inc, Irvine, CA, USA, 7. Allergan, Inc, Bridgewater, NJ, USA, 8. University of Toronto, Toronto, ON, Canada
Presenter
S Sender Herschorn
Abstract PDF Disclosure PDF Edit Abstract Abstract Centre